Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds

6 days ago

Marlborough, Massachusetts--(Newsfile Corp. - July 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) (the "Company"), a clinical stage biotechnology company…

EIR Supplements Introduces Longevity Formula for Cellular Health and Wellness

6 days ago

MIAMI, FL / ACCESSWIRE / July 12, 2024 / EIR Supplements, a leading innovator in health and wellness, is proud…

AMN Healthcare to Hold Second Quarter 2024 Earnings Conference Call on Thursday, August 8, 2024

6 days ago

DALLAS, July 12, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss…

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

6 days ago

DENVER, July 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports the initial commercial sale…

Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference

6 days ago

Vancouver, Canada, July 12, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

Shineco Announces Pricing of $2 Million Underwritten Public Offering

6 days ago

Beijing, July 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic…

Onco360 Selected as a Limited Distribution Specialty Pharmacy Partner for Rytelo™ (imetelstat)

6 days ago

LOUISVILLE, Ky., July 12, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a…

FluGen’s Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults Shows Superiority Over Flu Shot Alone

6 days ago

– Findings reported today in the journal Lancet Infectious Diseases– Study shows synergistic immunological response generated by M2SR and Fluzone High…

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

6 days ago

Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing…